Recent Presentations

For a comprehensive list of our presentations, abstracts, and posters visit our TCV Surgery Research presentations webpage.

American Thoracic Society, May 2010 New Orleans, LA

Sharma AK, Hajzus V, Kazemi A, Kron IL, and Laubach VE. NADPH oxidase-dependent activation of CD4+ T cells modulates macrophage and alveolar epithelial cell activation during lung ischemia-reperfusion injury.

Sharma AK, Zhao Y, LaPar D, Lau C, Kron IL, and Laubach VE. Pivotal role of NKT cells and IL-17 in pulmonary ischemia-reperfusion injury.

American Thoracic Society, May 2009 San Diego, CA

Sharma AK, Linden J, Kron IL, and Laubach VE.  CD4+ T cells modulate macrophage activation via IL-17 during lung ischemia-reperfusion injury.

American Association for Thoracic Surgery, May 2009   San Diego, CA

Sharma AK, Linden J, Kron IL, and Laubach VE.  CD4+ T cells modulate macrophage activation via IL-17 during lung ischemia-reperfusion injury.

American Thoracic Society, May 2008 Toronto, Canada

Fernandez LG, Peatross CM, Le Cras TD, Korfhagen TR, Kron IL and Laubach VE. Epidermal Growth Factor Receptor Signaling is Critical for Compensatory Lung Growth.

Sharma AK, Yang Z, Linden J, Kron IL and Laubach VE. Attenuation of Ischemia-Reperfusion Injury by Adenosine A2A Receptor Activation in a Buffer-perfused Mouse Lung Model.

Sharma AK, Yang Z, Linden J, Kron IL and Laubach VE. Pulmonary Ischemia-Reperfusion Injury is Mediated by CD4+ T Lymphocytes.

Sharma AK, Yang Z, Kron IL and LaubachVE. Oxidative Stress-Dependent Mechanisms of Pulmonary Ischemia-Reperfusion Injury.

American Association for Thoracic Surgery, May 2008   Toronto, Canada

Fernandez LG, Peatross CM, Le Cras TD, Korfhagen TR, Kron IL and Laubach VE. Epidermal Growth Factor Receptor Signaling is Critical for Compensatory Lung Growth.

Sharma AK, Yang Z, Linden J, Kron IL and V. E. Laubach VE. Attenuation of Ischemia-Reperfusion Injury by Adenosine A2A Receptor Activation in a Buffer-perfused Mouse Lung Model.

Sharma AK, Yang Z, Linden J, Kron IL and Laubach VE. Pulmonary Ischemia-Reperfusion Injury is Mediated by CD4+ T Lymphocytes.

Sharma AK, Yang Z, Kron IL and LaubachVE. Oxidative Stress-Dependent Mechanisms of Pulmonary Ischemia-Reperfusion Injury.

International Society for Heart and Lung Transplantation, April 2007  San Francisco, CA

A1, A2, or A3 adenosine receptor activation ameliorates lung ischemia reperfusion injury (Gazoni LM, Tribble CG, Unger EB, Ellman PI, Laubach VE, Linden J, and Kron IL)

American Association for Thoracic Surgery, May 2007   Washington D.C.

Pretreatment of donor lungs with the adenosine 2A receptor agonist ATL-313 results in superior protection from lung ischemia reperfusion injury versus administration during reperfusion (Gazoni LM, Laubach VE, Unger EB, Mulloy DP, Lisle T, Linden J, and Kron IL)

Southern Thoracic Surgical Association, Nov. 2006  Tucson, AZ

Pulmonary macrophage inhibition and inhaled nitric oxide attenuate lung ischemia reperfusion injury (Gazoni LM, Tribble CG, Zhao M, Unger EB,  Ellman PI, Fernandez LG, Laubach VE, Kron IL)

Southern Thoracic Surgical Association, Nov. 2005  Orlando, FL

Lung reperfusion injury can be modified by ventilation and perfusion techniques (Singh RR, Ellman PI, Warren PS, Laubach VE, Kron IL and Tribble CG)

American College of Surgeons Meeting, October 2003, Chicago, IL

Adenosine A2A analogue attenuates lung reperfusion injury (66.  Ellman PI, Tribble C, Maxey T, Tache-Leon C, Kern J, Laubach V, Linden J, Kron I)